Abstract:Gastric adenocarcinoma typically presents with advanced stage when inoperable. Chemotherapy options include non-targeted and toxic agents, leading to poor 5-year patient survival outcomes. Small molecule ONC201/TIC10 (TRAIL-Inducing Compound #10) induces cancer cell death via ClpP-dependent activation of the integrated stress response (ISR) and up-regulation of the TRAIL pathway. We previously found in breast cancer, pancreatic cancer and endometrial cancer that ONC201 primes tumor cells for TRAIL-mediated cell death through ISR-dependent upregulation of ATF4, CHOP and TRAIL death receptor DR5. We investigated the ability of ONC201 to induce apoptosis in gastric adenocarcinoma cells in combination with recombinant human TRAIL (rhTRAIL) or PEGylated trimeric TRAIL (TLY012). AGS (caspase 8-, KRAS-, PIK3CA-mutant, HER2-amplified), SNU-1 (KRAS-, MLH1-mutant, microsatellite unstable), SNU-5 (p53-mutant) and SNU-16 (p53-mutant) gastric adenocarcinoma cells were treated with ONC201 and TRAIL both in cell culture and in vivo. Gastric cancer cells showed synergy following dual therapy with ONC201 and rhTRAIL/TLY012 (combination indices < 0.6 at doses that were non-toxic towards normal fibroblasts). Synergy was observed with increased cells in the sub-G1 phase of the cell cycle with dual ONC201 plus TRAIL therapy. Increased PARP, caspase 8 and caspase 3 cleavage after ONC201 plus TRAIL further documented apoptosis. Increased cell surface expression of DR5 with ONC201 therapy was observed by flow cytometry, and immunoblotting revealed ONC201 upregulation of the ISR, ATF4, and CHOP. We observed downregulation of anti-apoptotic cIAP-1 and XIAP in all cells except AGS, and cFLIP in all cells except SNU-16. We tested the regimen in an organoid model of human gastric cancer, and in murine sub-cutaneous xenografts using AGS and SNU-1 cells. Our results suggest that ONC201 in combination with TRAIL may be an effective and non-toxic option for the treatment of gastric adenocarcinoma by inducing apoptosis via activation of the ISR, increased cell surface expression of DR5 and down-regulation of inhibitors of apoptosis. Our results demonstrate in vivo anti-tumor effects of ONC201 plus TLY012 against gastric cancer that could be further investigated in clinical trials.

ONTD Induces Apoptosis of Human Hepatoma Bel-7402 Cells Via a MAPK-dependent Mitochondrial Pathway and the Depletion of Intracellular Glutathione.

ONTD Induces Growth Arrest and Apoptosis of Human Hepatoma Bel-7402 Cells Though a Peroxisome Proliferator-Activated Receptor Γ-Dependent Pathway.

Osu-03012, A Novel Celecoxib Derivative, Induces A Unique Autophagy-Like Cell Death In Human Hepatocellular Carcinoma Cells

ONC206 targeting ClpP induces mitochondrial dysfunction and protective autophagy in hepatocellular carcinoma cells

The Inhibitory Effect of 3Β-Hydroxy-12-oleanen-27-oic Acid on Growth and Motility of Human Hepatoma HepG2 Cells Through JNK and Akt Signaling Pathway

Osu-03012, A Novel Celecoxib Derivative, Induces Reactive Oxygen Species-Related Autophagy In Hepatocellular Carcinoma

ONX0912, a Selective Oral Proteasome Inhibitor, Triggering Mitochondrial Apoptosis and Mitophagy in Liver Cancer.

ONC201 kills breast cancer cells in vitro by targeting mitochondria

(2E)-1-(2,4,6-trimethoxyphenyl)-3-(3-nitrophenyl)-2-propen-1-one Promotes Apoptosis By Regulating ERK/MAPK Pathway In Hepatocellular Carcinoma Cells

Oridonin Inhibits Cell Growth by Induction of Apoptosis on Human Hepatocelluar Carcinoma BEL-7402 Cells.

Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9

Mechanisms of Growth Inhibition and Apoptosis Inducement of Oridonin on Human Hepatic Carcinoma BEL-7402 Cells

Giganteaside D Induces ROS-mediated Apoptosis in Human Hepatocellular Carcinoma Cells Through the MAPK Pathway.

[Molecular Mechanism of Norcantharidin Inducing Apoptosis in Liver Cancer Cells].

NG, a Novel PABA/NO-based Oleanolic Acid Derivative, Induces Human Hepatoma Cell Apoptosis Via a ROS/MAPK-dependent Mitochondrial Pathway.

Oridonin Derivatives As Potential Anticancer Drug Candidates Triggering Apoptosis Through Mitochondrial Pathway in the Liver Cancer Cells

ONC201/TIC10 plus TLY012 anti-cancer effects via apoptosis inhibitor downregulation, stimulation of integrated stress response and death receptor DR5 in gastric adenocarcinoma

The novel glycyrrhetinic acid–tetramethylpyrazine conjugate TOGA induces anti-hepatocarcinogenesis by inhibiting the effects of tumor-associated macrophages on tumor cells

Norcantharidin (NCTD) induces mitochondria mediated apoptosis in human HepG2 cells

Involvement of Mitochondrial Pathway in NCTD-induced Cytotoxicity in Human Hepg2 Cells.

A New Oridonin Analog Suppresses Triple-Negative Breast Cancer Cells and Tumor Growth Via the Induction of Death Receptor 5